GLDM Stock Price Chart
Daily OHLCV with technical indicators — pan, zoom, and customize your view
04
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits1
Ex-date
Split
Type
Feb. 23, 2022
1-for-2
Reverse
10-Year Performance
Revenue, net income, margins and EPS trends
06
Valuation & Ratios07–12
Valuation
P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Profitability
Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
GLDM
5Y avg
Peer Median
Verdict
ROA
35.4%5Y avg ≈7.6%
≈7.6%
·
·
Financial Health
Debt, liquidity, solvency — balance sheet strength
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Growth
Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
GLDM
5Y avg
Peer Median
Verdict
Net Income YoY
119.1%
·
·
·
Net Income CAGR 3Y
7.2%
·
·
·
Net Income CAGR 5Y
64.3%
·
·
·
Per Share Metrics
EPS, book value per share, cash flow per share, dividend per share
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency
Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals
All metrics by year — income statement, balance sheet, cash flow
15
Income Statement4
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Operating Expenses
$13M
$7M
$6M
$6M
$7M
$3M
$1M
$145.0K
$77.0K
Net Income
$5.31B
$2.42B
$546M
$-295M
$-346M
$443M
$139M
$-8M
$-337.0K
EPS (Basic)
$25.06
$15.19
$3.56
$-2.23
$-3.01
·
·
·
$-1.80
Shares (Basic)
211,884,000
159,487,000
153,402,000
132,493,000
114,791,000
·
·
·
187,000
Balance Sheet3
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Cash & Equivalents
·
·
·
·
·
·
·
·
$0
Total Assets
$20.86B
$9.16B
$5.78B
$4.69B
$4.39B
$3.56B
$1.05B
$255M
$14M
Total Liabilities
$2M
$53M
$15M
$53M
$666.0K
$517.0K
$148.0K
$30.0K
$54.0K
Cash Flow7
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Operating Cash Flow
$0
$0
$0
$0
$0
$0
$0
$0
$0
Stock Issued
·
·
·
·
$0
$0
$0
$0
$1.0K
Stock Repurchased
·
·
·
·
$0
$0
$0
$0
$1.0K
Net Stock Activity
·
·
·
·
$0
$0
$0
·
$0
Dividends Paid
·
·
·
·
$0
$0
$33M
$0
·
Financing Cash Flow
·
·
·
·
$0
$0
$0
$0
$0
Net Change in Cash
$0
$0
$0
$0
$0
·
·
$0
$0
Profitability1
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
ROA
35.4%
·
10.4%
-6.5%
-8.7%
19.2%
21.3%
-5.6%
-4.7%
Growth Rates3
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Net Income YoY
119.1%
343.6%
·
·
·
·
·
·
·
Net Income CAGR 3Y
·
·
7.2%
·
·
·
·
·
·
Net Income CAGR 5Y
64.3%
·
·
·
·
·
·
·
·
Valuation (TTM)3
Metric
Trend
2025
2024
2023
2022
2021
2020
2019
2018
2017
Net Income TTM
$5.31B
$2.42B
$546M
$-295M
$-346M
$443M
$139M
$-8M
$-337.0K
Payout Ratio
·
·
·
·
0.00%
0.00%
24.1%
·
·
Annual Payout
·
·
·
·
$0
$0
$33M
$0
·
Income Statement4
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022
Q3 2021
Operating Expenses
$8M
$8M
$6M
$4M
$3M
$2M
$2M
$2M
$2M
$2M
$1M
$1M
$1M
$2M
$2M
$2M
Net Income
$-4.00B
$1.65B
$2.69B
$709M
$1.90B
$-71M
$370M
$474M
$582M
$-225M
$498M
$400M
$-355M
$289M
$186M
$159M
EPS (Basic)
·
·
·
$3.13
$10.05
$-0.40
$2.31
$3.03
$3.81
$-1.39
$3.26
$2.81
$-2.52
$2.35
$1.54
$1.32
Shares (Basic)
·
·
·
226,343,000
188,797,000
176,051,000
159,942,000
156,214,000
152,788,000
161,465,000
152,769,000
142,422,000
141,035,000
123,023,000
120,793,000
120,535,000
Balance Sheet2
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022
Q3 2021
Total Assets
$27.30B
$29.62B
$25.29B
$15.68B
$13.23B
$9.21B
$7.40B
$6.99B
$6.36B
$6.16B
$6.09B
$5.16B
$5.09B
$5.22B
$4.36B
$4.33B
Total Liabilities
$42M
$3M
$2M
$1M
$1M
$788.0K
$605.0K
$571.0K
$527.0K
$518.0K
$501.0K
$8M
$425.0K
$420.0K
$651.0K
$662.0K
Cash Flow2
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022
Q3 2021
Operating Cash Flow
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Net Change in Cash
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
·
Profitability1
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022
Q3 2021
ROA
-18.6%
7.7%
15.6%
6.1%
18.8%
-0.91%
5.5%
7.2%
10.1%
-4.0%
8.8%
8.4%
-7.5%
6.3%
4.4%
4.6%
Valuation (TTM)1
Metric
Trend
Q3 2026
Q2 2026
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Q1 2024
Q3 2023
Q2 2023
Q1 2023
Q3 2022
Q2 2022
Q1 2022
Q3 2021
Net Income TTM
$3.12B
$7.82B
$8.07B
$3.53B
$3.19B
$1.77B
$1.30B
$704M
$728M
$258M
$128M
$-81M
$63M
$577M
$-165M
$-128M
Most recent period on the left · null values shown as ·
Financial Statements
Income statement, balance sheet, cash flow — annual, last 5 years
16
Metric
2025-09-30
2024-09-30
2023-09-30
2022-09-30
2021-09-30
Net Income
$5.31B
$2.42B
$546M
$-295M
$-346M
No data for this statement
Not enough fundamentals data to build this statement yet.
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F)
963 filers
· $14.2B total
· As of June 30, 2026
17
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders963
Value held$14.2B
New positions99
Exited positions84
Institutional activity — Q2 2026 vs prior quarter
New positions
Exited positions
Increased
Decreased
Net shares change
99 (-32 vs prior Q)
84 (+12 vs prior Q)
395 (+114 vs prior Q)
262 (-110 vs prior Q)
+17.4M
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.